Skye Bioscience
SKYE· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -73.5% in FY2025
Punit Dhillon is the CEO of Skye Bioscience and was paid $1.4M in FY2025 (Dec), down 78%.
Pay$100 in the stock at the end of FY24 → $26
Executives3
See all- 1Punit DhillonChief Executive OfficerFY2025
- 2Kaitlyn ArsenaultFormer Chief Financial OfficerFY2025
- 3Tu DiepChief Operating OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allSkye Bioscience paid its 3 named executives $3.1M in total in FY2025 (Dec). CEO Punit Dhillon was paid $1.4M of that.
| Name | |||
|---|---|---|---|
| Punit DhillonChief Executive Officer | |||
| Kaitlyn ArsenaultFormer Chief Financial Officer | |||
| Tu DiepChief Operating Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Skye Bioscience. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Paul GraysonChair · 2 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive
- Annalisa JenkinsDirector · 1 yr on the boardIndependentAudit (Chair), Compensation, Nominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 16, 2026 | FY2025 |
| Annual report | 10-K | Mar 10, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Sep 23, 2024 | FY2023 |
| Annual report | 10-K | Mar 22, 2024 | FY2023 |